Cinsebrutinib

Modify Date: 2024-07-31 11:11:33

Cinsebrutinib structure	Common Name	Cinsebrutinib
	CAS Number	2724962-58-5	Molecular Weight	383.46
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₂H₂₆FN₃O₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Cinsebrutinib

Cinsebrutinib is a Bruton's tyrosine kinase inhibitor, extracted from patent WO2021207549 (compound 5-6). Cinsebrutinib has the potential for cancer study.

Name	Cinsebrutinib

Description	Cinsebrutinib is a Bruton's tyrosine kinase inhibitor, extracted from patent WO2021207549 (compound 5-6). Cinsebrutinib has the potential for cancer study.
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Btk
References	[1]. Coburn, Craig Alan, et al. Preparation of pyridoindolecarboxamides and their analogs as BTK kinase inhibitors. WO2021207549.

Molecular Formula	C₂₂H₂₆FN₃O₂
Molecular Weight	383.46
InChIKey	NEHJPDSXWUIXGI-CYBMUJFWSA-N
SMILES	C=CC(=O)N1CCCC(c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CCCCC4)C1

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Palmitic acid
Price: Check
Purity: 98.0%
Delivery: 10 Day
Contact: Yang
Email: sales@echemcloud.com